2010
DOI: 10.1016/j.athoracsur.2010.04.006
|View full text |Cite
|
Sign up to set email alerts
|

Thirty-Year Follow-Up Defines Survival Benefit for Second Internal Mammary Artery in Propensity-Matched Groups

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

9
165
0
2

Year Published

2012
2012
2020
2020

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 199 publications
(177 citation statements)
references
References 21 publications
9
165
0
2
Order By: Relevance
“…В 2001 году в систематическом обзоре, в котором сравнивали шунтирование с одной ВГА (SIMA), по сравнению с билатеральным шунтированием ВГА (BIMA) была отмечена достоверно лучшая выживае-мость пациентов при шунтировании BIMA, с относи-тельным риском смерти 0,81 [410]. Недавно прове-денные исследования показали, что польза двусто-роннего шунтирования ВГА (BIMA) в отношении выживаемости сохраняется на втором и третьем деся-тилетии периода наблюдения [411,412], и особенно у пациентов с сахарным диабетом [169].…”
Section: Iib B 373-375unclassified
“…В 2001 году в систематическом обзоре, в котором сравнивали шунтирование с одной ВГА (SIMA), по сравнению с билатеральным шунтированием ВГА (BIMA) была отмечена достоверно лучшая выживае-мость пациентов при шунтировании BIMA, с относи-тельным риском смерти 0,81 [410]. Недавно прове-денные исследования показали, что польза двусто-роннего шунтирования ВГА (BIMA) в отношении выживаемости сохраняется на втором и третьем деся-тилетии периода наблюдения [411,412], и особенно у пациентов с сахарным диабетом [169].…”
Section: Iib B 373-375unclassified
“…The two seminal retrospective studies from the Cleveland clinic had shown that bilateral ITAs not only confer a survival benefit in patients undergoing CABG (7), but also extend this benefit further as one moves away from the time of surgery (8). Several large meta-analyses (9-11) and propensity-matched observational studies have also confirmed the benefits of bilateral ITA utilization during CABG (12,13). However, the Arterial Revascularization Trial (ART), which is the only randomized controlled trial (RCT) comparing the use of single with bilateral ITA during CABG, revealed no survival benefit or reduction in the rates of cardiovascular events in favour of the latter at least till the 5-year followup mark (14), thereby throwing the debate wide open.…”
Section: Introductionmentioning
confidence: 85%
“…The single most important benefit of using bilateral ITAs is the superior long-term survival, which has been demonstrated by several observational studies (7,8,13) and meta-analyses (9-11). However, long-term survival following off-pump CABG has always been a matter of debate.…”
Section: Discussionmentioning
confidence: 99%
“…The demonstrated clinical advantages of BIMA grafting strategies include prolonged survival and reduced need for coronary reintervention on the basis of recurrent myocardial ischemia, including freedom from the need for coronary reintervention [15,88,90] which hold true for women as well as for men, where it has been demonstrated that use of BIMA had 3-fold improved cardiacrelated survival compared with patients who did not receive an IMA graft [91]. Reported rates of BIMA use in CABG range from 4.0% to nearly 50% depending upon several factors including the contributing authors' practice preferences and the particular patient cohort treated [19][20][21][22]92]. However, it has been estimated that up to 80% would be candidates for BIMA grafting [93].…”
Section: Bilateral Internal Mammary Artery Conduitsmentioning
confidence: 99%